The fate of the medical device excise tax continued to get some high-profile attention last week in the midst of ongoing fiscal-cliff negotiations in Washington, D.C.
While the prospects of an outright repeal of the 2.3% excise tax by the end of the year are dimming, the chances that the tax could be delayed from its scheduled Jan. 1 start date seemed to improve measurably with a recent
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?